Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714532 · ClinicalTrials.gov registry record · NA
Smoking Reduction and Cessation Interventions for Chinese
A NA study of Smoking Cessation, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 1
- Study location
NCT00714532 is a NA study of Smoking Cessation that has completed, run by University of California, San Francisco. The registered enrollment target is 298 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00714532, a NA study of Smoking Cessation, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoking abstinence, quit attempts, and smoking reduction at 12 months.
Conditions Studied
Interventions
- BEHAVIORAL Expert System Only
- BEHAVIORAL Enhanced Expert System
Study Locations (1)
California
- UCSF Langley Porter - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00714532
The ClinicalTrials.gov registry entry for NCT00714532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (37% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Expert System Only is the first listed.
NCT00714532 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00714532 about?
NCT00714532 is a clinical study titled "Smoking Reduction and Cessation Interventions for Chinese". This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoki...
What is the current status of trial NCT00714532?
This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2007-04. Estimated completion is 2009-06.
What conditions does trial NCT00714532 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00714532?
The interventions under investigation include: Expert System Only (BEHAVIORAL), Enhanced Expert System (BEHAVIORAL).
Who is sponsoring clinical trial NCT00714532?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00714532 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.